Fisher Asset Management LLC Decreases Position in Axon Enterprise, Inc. (NASDAQ:AXON)

Fisher Asset Management LLC decreased its stake in Axon Enterprise, Inc. (NASDAQ:AXON) by 2.3% in the third quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 775 shares of the biotechnology company’s stock after selling 18 shares during the quarter. Fisher Asset Management LLC’s holdings in Axon Enterprise were worth $310,000 at the end of the most recent reporting period.

Several other large investors have also recently modified their holdings of the stock. Quent Capital LLC raised its position in Axon Enterprise by 1,875.0% in the 3rd quarter. Quent Capital LLC now owns 79 shares of the biotechnology company’s stock worth $32,000 after purchasing an additional 75 shares during the period. Blue Trust Inc. raised its holdings in shares of Axon Enterprise by 987.5% in the second quarter. Blue Trust Inc. now owns 87 shares of the biotechnology company’s stock worth $27,000 after buying an additional 79 shares during the period. Planning Capital Management Corp lifted its stake in shares of Axon Enterprise by 83.3% during the 3rd quarter. Planning Capital Management Corp now owns 121 shares of the biotechnology company’s stock worth $48,000 after acquiring an additional 55 shares during the last quarter. Friedenthal Financial purchased a new position in Axon Enterprise during the 3rd quarter valued at $51,000. Finally, Reston Wealth Management LLC bought a new position in Axon Enterprise in the 3rd quarter valued at $60,000. Institutional investors own 79.08% of the company’s stock.

Insider Activity

In related news, CEO Patrick W. Smith sold 75,000 shares of the company’s stock in a transaction dated Tuesday, September 3rd. The stock was sold at an average price of $356.53, for a total transaction of $26,739,750.00. Following the transaction, the chief executive officer now directly owns 2,970,366 shares of the company’s stock, valued at $1,059,024,589.98. This represents a 2.46 % decrease in their position. The sale was disclosed in a filing with the SEC, which is available at this link. Also, President Joshua Isner sold 25,811 shares of the firm’s stock in a transaction dated Tuesday, September 10th. The stock was sold at an average price of $359.84, for a total value of $9,287,830.24. Following the completion of the sale, the president now directly owns 228,166 shares of the company’s stock, valued at approximately $82,103,253.44. This represents a 10.16 % decrease in their position. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 210,256 shares of company stock worth $87,783,120. Corporate insiders own 6.10% of the company’s stock.

Axon Enterprise Price Performance

Shares of AXON stock opened at $646.96 on Monday. The company has a market cap of $49.33 billion, a P/E ratio of 167.17, a PEG ratio of 14.24 and a beta of 0.94. The company has a debt-to-equity ratio of 0.32, a current ratio of 2.96 and a quick ratio of 2.63. The stock’s 50-day moving average is $488.25 and its 200 day moving average is $379.59. Axon Enterprise, Inc. has a 1-year low of $224.28 and a 1-year high of $652.22.

Analysts Set New Price Targets

Several analysts have recently weighed in on the company. Needham & Company LLC lifted their target price on Axon Enterprise from $525.00 to $600.00 and gave the stock a “buy” rating in a research report on Friday, November 8th. Northland Securities lifted their price objective on shares of Axon Enterprise from $365.00 to $550.00 and gave the company an “outperform” rating in a report on Monday, November 11th. The Goldman Sachs Group upped their target price on shares of Axon Enterprise from $385.00 to $441.00 and gave the stock a “buy” rating in a research note on Wednesday, October 23rd. Barclays lifted their price target on shares of Axon Enterprise from $381.00 to $387.00 and gave the company an “overweight” rating in a research note on Wednesday, August 7th. Finally, Robert W. Baird increased their price objective on Axon Enterprise from $440.00 to $460.00 and gave the stock an “outperform” rating in a research note on Monday, November 4th. Two research analysts have rated the stock with a hold rating and twelve have given a buy rating to the stock. According to data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $427.83.

Axon Enterprise Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.